Key Events This Week
31 Aug: Stock opens at Rs.46.25, down 1.47% amid broad market weakness
1 Sep: Formation of Golden Cross signals potential bullish breakout
2 Sep: Mojo Grade upgraded from Strong Sell to Sell despite weak fundamentals
4 Sep: Week closes at Rs.45.60, down 0.31% on the day

Zenotech Laboratories Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals
2026-09-02 08:31:19Zenotech Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced shift in technical indicators despite ongoing financial challenges. The change, effective from 1 September 2026, is driven primarily by an improved technical outlook, while valuation and financial trends remain under pressure in the pharmaceuticals and biotechnology sector.
Read full news article
Golden Cross Forms in Zenotech Laboratories Ltd — On a Day the Stock Gained 0.32%. What the Mixed Signals Mean
2026-09-01 18:00:27The 50-day moving average has crossed above the 200-day moving average for Zenotech Laboratories Ltd, signalling a golden cross on 1 Sep 2026. Yet, the stock’s modest 0.32% gain on the day and a mixed set of technical indicators suggest the signal warrants a nuanced interpretation rather than straightforward optimism.
Read full news article
Zenotech Laboratories Ltd is Rated Strong Sell
2026-09-01 10:11:23Zenotech Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 29 July 2026, reflecting a change from the previous 'Sell' grade. However, the analysis and financial metrics discussed below represent the stock's current position as of 01 September 2026, providing investors with the latest insights into the company's performance and outlook.
Read full news article
Zenotech Laboratories Ltd is Rated Strong Sell
2026-08-21 10:10:59Zenotech Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 29 July 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 21 August 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Zenotech Laboratories Ltd is Rated Strong Sell
2026-08-10 10:11:04Zenotech Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 29 July 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 10 August 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news articleZenotech Laboratories Gains 0.56%: 3 Key Factors Driving the Week’s Move
2026-08-01 16:06:16
Key Events This Week
27 Jul: Stock opens week with a 1.83% gain to Rs.45.10
28 Jul: Q1 FY27 results reveal deepening losses, stock falls 2.06%
30 Jul: Quality grade downgraded to average; Mojo rating cut to Strong Sell
31 Jul: Week closes at Rs.44.54, up 0.20% on the day but below week open

Zenotech Laboratories Downgraded to Strong Sell Amid Deteriorating Fundamentals
2026-07-30 08:13:57Zenotech Laboratories Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 29 July 2026, reflecting deteriorating fundamentals across quality, valuation, financial trends, and technical indicators. The pharmaceutical company’s weakening operating performance, expensive valuation metrics, and persistent underperformance against benchmarks have prompted a reassessment of its outlook by analysts.
Read full news articleAnnouncement under Regulation 30 (LODR)-Newspaper Publication
29-Aug-2026 | Source : BSENewspaper publication informing about 37th Annual General Meeting & e-Voting.
Reg. 34 (1) Annual Report.
28-Aug-2026 | Source : BSEAnnual Report 2025-26 and the Notice of 37th Annual General Meeting
Notice Of 37Th Annual General Meeting To Be Held On Friday September 25 2026 Along With Annual Report For The FY 2025-26.
28-Aug-2026 | Source : BSENotice of 37th Annual General Meeting along with Annual Report for the FY 2025-26
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
Zenotech Laboratories Ltd has announced 17:22 rights issue, ex-date: 01 Jun 17







